NextGen Healthcare (NASDAQ:NXGN) updated its third quarter earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $0.24-0.26 for the period, compared to the Thomson Reuters consensus estimate of $0.20. The company issued revenue guidance of $140-142 million, compared to the consensus revenue estimate of $137.37 million.NextGen Healthcare also updated its FY21 guidance to $0.92-0.98 EPS.
Several equities analysts have commented on NXGN shares. Piper Sandler cut their price target on NextGen Healthcare from $23.00 to $21.00 and set an overweight rating for the company in a report on Friday, October 23rd. SVB Leerink upped their price target on shares of NextGen Healthcare from $12.00 to $14.00 and gave the stock a market perform rating in a research report on Friday, October 23rd. Colliers Securities restated a buy rating on shares of NextGen Healthcare in a research report on Friday, December 11th. Morgan Stanley upped their target price on shares of NextGen Healthcare from $12.00 to $14.00 and gave the company an underweight rating in a research report on Monday, October 26th. Finally, BidaskClub raised NextGen Healthcare from a hold rating to a buy rating in a research note on Thursday, October 8th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company. The stock has an average rating of Hold and a consensus price target of $13.13.
NASDAQ:NXGN opened at $20.47 on Wednesday. NextGen Healthcare has a 12 month low of $5.10 and a 12 month high of $20.59. The company has a 50 day simple moving average of $18.30 and a two-hundred day simple moving average of $14.55. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.15. The company has a market cap of $1.37 billion, a PE ratio of 127.95, a price-to-earnings-growth ratio of 3.33 and a beta of 1.23.
In related news, Director George H. Bristol sold 4,800 shares of the stock in a transaction that occurred on Thursday, December 3rd. The shares were sold at an average price of $17.52, for a total transaction of $84,096.00. Following the completion of the transaction, the director now owns 67,061 shares of the company’s stock, valued at approximately $1,174,908.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 18.70% of the stock is currently owned by insiders.
NextGen Healthcare Company Profile
NextGen Healthcare, Inc provides ambulatory-focused healthcare software and services solutions in the United States. The company offers NextGen Enterprise electronic health record (EHR), which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Featured Story: Understanding Market Liquidity
Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.